• Investing Ideas
  • /
  • Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
106 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2269

WuXi Biologics (Cayman)
HK$14.042.0%-69.8%HK$58.6bHK$31.40PE15.9xE14.4%n/a

512

Grand Pharmaceutical Group
HK$4.07-3.3%-10.9%HK$14.3bn/aPE7.6xE20.0%6.4%

1877

Shanghai Junshi Biosciences
HK$9.961.5%-64.5%HK$24.4bHK$31.58PS6xE51.6%n/a

1093

CSPC Pharmaceutical Group
HK$6.19-1.3%-18.7%HK$73.3bHK$9.35PE11.5xE4.5%4.5%

1093

CSPC Pharmaceutical Group
HK$6.19-1.3%-18.7%HK$73.3bHK$9.35PE11.5xE4.5%4.5%

3347

Hangzhou Tigermed Consulting
CN¥29.401.2%-58.3%CN¥40.6bCN¥37.81PE21.5xE13.7%1.1%

3759

Pharmaron Beijing
CN¥9.583.3%-56.7%CN¥33.0bCN¥12.11PE22.8xE12.3%1.0%

6826

Shanghai Haohai Biological Technology
HK$39.40-0.3%1.5%HK$15.8bHK$70.01PE14.6xE22.4%2.7%

690

Uni-Bio Science Group
HK$0.0781.3%39.3%HK$480.8mn/aPE6.8xn/an/a

3737

Zhongzhi Pharmaceutical Holdings
HK$1.16-4.1%11.5%HK$1.0bn/aPE5.7xn/a5.2%

9939

Kintor Pharmaceutical
HK$1.15-17.3%-86.4%HK$514.6mHK$16.05PB0.3xE4.0%n/a

2633

Jacobson Pharma
HK$0.580%-38.9%HK$1.2bn/aPE4.7xn/a8.4%

2269

WuXi Biologics (Cayman)
HK$14.042.0%-69.8%HK$58.6bHK$31.40PE15.9xE14.4%n/a

6160

BeiGene
US$92.60-0.05%-29.0%US$16.0bUS$162.76PS6.5xE56.6%n/a

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.200%-9.8%HK$1.8bn/aPE5.1xn/a6.6%

3347

Hangzhou Tigermed Consulting
CN¥29.401.2%-58.3%CN¥40.6bCN¥37.81PE21.5xE13.7%1.1%

6160

BeiGene
US$92.60-0.05%-29.0%US$16.0bUS$162.76PS6.5xE56.6%n/a

512

Grand Pharmaceutical Group
HK$4.07-3.3%-10.9%HK$14.3bn/aPE7.6xE20.0%6.4%

3759

Pharmaron Beijing
CN¥9.583.3%-56.7%CN¥33.0bCN¥12.11PE22.8xE12.3%1.0%

239

Pak Fah Yeow International
HK$2.060.5%60.9%HK$642.0mn/aPE6.1xn/a10.0%

1548

Genscript Biotech
HK$14.381.3%-13.7%HK$30.5bHK$28.84PS4.6xE89.5%0%

1521

Frontage Holdings
HK$1.40-0.7%-35.8%HK$2.8bHK$1.85PE33.5xE25.1%n/a

1652

Fusen Pharmaceutical
HK$0.90-5.3%-33.3%HK$666.6mn/aPS1.1xn/a0%

6185

CanSino Biologics
HK$17.088.2%-58.6%HK$8.5bHK$26.10PS10.9xE124.2%0%
Page 3 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.